Welcome to our dedicated page for Icl Group Ltd. SEC filings (Ticker: ICL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking fertilizer demand swings or gauging potash margins across four continents means digging through hundreds of pages of ICL disclosures鈥攅ach packed with mineral-reserve tables, environmental commitments, and commodity risk factors. If you have ever typed 鈥淚CL SEC filings explained simply鈥� or searched for 鈥淚CL insider trading Form 4 transactions,鈥� you know how time-consuming that task can be.
Stock Titan solves the problem with AI-powered summaries that translate technical jargon into plain English. AG真人官方-time alerts let you follow 鈥淚CL Form 4 insider transactions real-time,鈥� while side-by-side comparisons turn the latest 鈥淚CL quarterly earnings report 10-Q filing鈥� into actionable insight. Whether you need an 鈥淚CL annual report 10-K simplified鈥� or rapid 鈥淚CL earnings report filing analysis,鈥� our platform highlights segment revenue shifts, potash pricing sensitivity, and ESG liabilities the moment they hit EDGAR.
Wondering where to locate specific information? Use our coverage map below:
- Form 4: 鈥淚CL executive stock transactions Form 4鈥� with instant flags on director buys and sells.
- 10-K & 10-Q: Consolidated mining costs, phosphate capacity, and global sales鈥攁ll summarized for 鈥渦nderstanding ICL SEC documents with AI.鈥�
- 8-K: 鈥淚CL 8-K material events explained,鈥� from mine-shutdown notices to pricing updates.
- DEF 14A: 鈥淚CL proxy statement executive compensation鈥� parsed to reveal pay tied to commodity benchmarks.
Every filing鈥攆rom environmental impact exhibits to covenant details鈥攊s updated the moment it posts, so you can stop refreshing EDGAR. Make better decisions, faster, with complete coverage of ICL filings in a single, intelligent workspace.
Jaguar Health, Inc. (NASDAQ: JAGX) received SEC notice that its Form S-3 shelf registration statement (File No. 333-288202) became effective on June 27, 2025 at 4:00 p.m. ET. The effectiveness allows the company to register and potentially issue securities in the future without additional SEC review, streamlining capital-raising activities. No financial terms, transaction details, or earnings information were disclosed in the notice.
ICL Group (NYSE:ICL) filed a Form 6-K detailing the execution of new 2025 potash supply contracts with its two largest Asian customers.
China: ICL will deliver 750,000 metric tons under its 2025-2027 framework, with an optional +340,000 t. Pricing is set at $346/t CIFFO, mirroring recent Chinese settlements.
India: Under the 2022-2027 agreement with Indian Potash Ltd., the company will supply 400,000 t, plus an option for +100,000 t, at $349/t CIFFO delivered to Indian ports.
The contracts secure up to 1.59 million tons of 2025 potash off-take, providing visibility on volume and price in core markets. The filing is incorporated by reference into ICL鈥檚 Form S-8 and Israeli shelf prospectus and contains no additional financial statements.
FAQ
What is the current stock price of Icl Group Ltd. (ICL)?
What is the market cap of Icl Group Ltd. (ICL)?
What is the primary business focus of ICL Group Ltd.?
Which markets does ICL serve?
How is ICL Group structured in terms of business segments?
How does ICL integrate technology into its operations?
What makes ICL's product offerings significant in the market?
How does ICL maintain its competitive position globally?
Are there any recent technological collaborations by ICL?
How does ICL contribute to the agricultural industry?
